Target intelligence / Profile preview

Nephron ion transporter (none commonly used; individual transporter abbreviations exist (e.g., ENaC, NKCC2, NaPi-IIa))

Target
none commonly used; individual transporter abbreviations exist (e.g., ENaC, NKCC2, NaPi-IIa)
Molecular classification
Transporter, Ion channel, ATPase (ion pump), Symporter, Antiporter, Receptor (indirectly in rare cases)
01

Overview

Nephron ion transporters are a family of membrane proteins located throughout the nephron—the functional unit of the kidney—facilitating the movement of ions such as sodium, potassium, chloride, calcium, and phosphate across epithelial cells. They operate through a variety of mechanisms, including coupled transport (symport, antiport), active pumping (ATPase), and passive channel activity, and are essential for kidney functions such as filtration, reabsorption, secretion, and maintenance of internal body electrolyte and fluid homeostasis[3][5][7][9]. Many nephron ion transporters serve as critical drug targets for diuretic, antihypertensive, and antidiabetic therapies, and their dysfunction is implicated in numerous kidney and systemic diseases[4][6][8]. The group encompasses individual proteins such as ENaC, NKCC2, NaPi-IIa, ROMK, and various organic ion transporters, each with specific roles and clinical significance.

Other names
Renal ion transporterKidney ion transporterTubular ion transporterNephron transporterIndividual transporter names: Epithelial sodium channel (ENaC)Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2/BSC1)Sodium-phosphate cotransporter (NaPi-IIa)Renal outer medullary potassium channel (ROMK)Transient receptor potential channels (TRPV5/TRPV6)Sodium-potassium ATPase
02

Mechanism of action

Inhibition of ion reabsorption (causing increased renal excretion, e.g., natriuresis); Blockade of transporter activity, altering electrolyte and water balance; Modulation of acid-base homeostasis (via transporter targeting)[4][7]; Induction of diuresis; Promotion or inhibition of cellular ion exchange[2]

03

Biological functions

Ion transport (Na⁺, K⁺, Cl⁻, Ca²⁺, Mg²⁺, PO₄³⁻, HCO₃⁻, etc.)Water reabsorption/regulationAcid-base balanceCellular homeostasisRenal excretion of waste (via ion coupling)Cell signaling (for some channel types)
04

Disease associations

Cardiovascular disease (e.g., hypertension)Chronic kidney disease (CKD)Electrolyte disorders (e.g., hyperkalemia, hyponatremia)Kidney stone formationTubulopathies (e.g., Bartter syndrome, Gitelman syndrome)EdemaDiabetes (for some transporters, e.g., SGLT2)
05

Safety considerations

Electrolyte disturbances (hyponatremia, hyper/hypokalemia, hypomagnesemia)[3][4][7]Volume depletion (leading to hypotension, dehydration)Risk of nephrotoxicity or renal injuryHyperglycemia or hypoglycemia (with SGLT2 inhibitors)[4]Off-target effects due to transporter similarity[4]
06

Interacting drugs

Thiazide diuretics (target NCC transporters)

6 more in the full profile.

07

Biomarkers

Urine electrolyte levels (Na⁺, K⁺, Cl⁻, etc.)Fractional excretion of ions (e.g., FeNa)Plasma creatinine/urea (for renal function monitoring)Serum phosphate (for phosphate transporter modulation)Specific transporter expression (sometimes used in research/clinical trials)

Beyond the preview

Go deeper on Nephron ion transporter (none commonly used; individual transporter abbreviations exist (e.g., ENaC, NKCC2, NaPi-IIa)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephron ion transporter (none commonly used; individual transporter abbreviations exist (e.g., ENaC, NKCC2, NaPi-IIa)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call